Calibre Scientific Acquires NeXtal Biotechnologies from Qiagen

January 8, 2020

Calibre Scientific has acquired the NeXtal Biotechnologies line of structural biology products (including EasyXtal crystallization plates) from Qiagen NV. The purchase expands Calibre's structural biology and protein crystallization product portfolio, supplying academic, biotechnology, and pharmaceutical customers.

Buyers
Calibre Scientific
Targets
NeXtal Biotechnologies
Sellers
Qiagen NV
Industry
Biotechnology
Location
Ohio, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.